Mirko Baruscotti Selected Research

licoisoflavone A

3/2020

High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mirko Baruscotti Research Topics

Disease

3	Epilepsy (Aura) 10/2018 - 07/2010
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 03/2020
2	Hypertrophy 01/2022 - 03/2020
2	Bradycardia 11/2017 - 01/2006
2	Sinus Tachycardia 01/2017 - 10/2012
2	Channelopathies 08/2015 - 07/2010
2	Stable Angina 01/2013 - 04/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2020
1	Heart Failure 03/2020
1	Infantile Epileptic-Dyskinetic Encephalopathy 10/2018
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Atrioventricular Block 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2017
1	Idiopathic Generalized Epilepsy 11/2011

Drug/Important Bio-Agent (IBA)

3	Ion Channels (Ion Channel)IBA 10/2018 - 01/2006
3	IvabradineIBA 01/2013 - 04/2007
2	Pharmaceutical PreparationsIBA 03/2020 - 01/2018
2	Protein Isoforms (Isoforms)IBA 10/2018 - 07/2010
2	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 01/2017 - 11/2011
2	Reducing AgentsIBA 01/2013 - 04/2007
1	CalciumIBA 01/2022
1	herbacetinIBA 01/2022
1	FlavonoidsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Angiotensin IIIBA 03/2020
1	Emodin (Archin)IBA 03/2020
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2020
1	tongmaiyangxinIBA 03/2020
1	licoisoflavone AIBA 03/2020
1	Therapeutic UsesIBA 03/2020
1	Sirtuin 3IBA 03/2020
1	AmberIBA 01/2018
1	Terfenadine (Seldane)IBA 01/2018
1	wenxin keliIBA 01/2018
1	Caveolin 3IBA 08/2017
1	Proteins (Proteins, Gene)FDA Link 08/2015

Therapy/Procedure

1	Therapeutics 01/2022
1	Endurance Training 11/2017